Good morning, ladies and gentlemen, and welcome to the Celestica Q4 2022 Earnings Conference Call. At this time, all lines are in listen-only mode. Following the presentation, we'll conduct a Q&A session. If at any time during this call you require any assistance, please press star zero for the operator. This call is being recorded on Thursday, January 26th, 2023. I would now like to turn the conference over to Craig Oberg. Please go ahead. Good morning. Thank you for joining us on Celestica's Q4 2022 earnings conference call. On the call today are Rob Mionis, President and Chief Executive Officer, and Mandeep Chawla, Chief Financial Officer. As a reminder, during this call, we will make forward-looking statements within the meanings of the U.S. Private Securities Litigation Reform Act of 1995 and applicable Canadian securities laws. Such forward-looking statements are based on management's current expectations, forecasts, and assumptions, which are subject to risks, uncertainties, and other factors that could cause actual outcomes and results to differ materially from conclusions, forecasts, or projections expressed in such statements. For identification and discussion of such factors and assumptions, as well as further information concerning forward-looking statements, please refer to yesterday's press release, including the cautionary note regarding forward-looking statements therein, our most recent annual report on Form 20-F, and other public filings, which can be accessed at sec.gov and sedar.com. We assume no obligation to update any forward-looking statement except as required by law. In addition, during this call, we will refer to various non-IFRS financial measures, including ratios based on non-IFRS financial measures consisting of non-IFRS operating margin, adjusted gross margin, adjusted return on invested capital or adjusted ROIC, adjusted free cash flow, gross debt to non-IFRS trailing twelve-month adjusted EBITDA leverage ratio, adjusted earnings per share or adjusted EPS, adjusted SG&A expense, Lifecycle Solutions revenue, and adjusted effective tax rate. Listeners should be cautioned that references to any of the foregoing measures during this call denote non-IFRS financial measures, whether or not specifically designated as such. These non-IFRS financial measures do not have any standardized meanings prescribed by IFRS and may not be comparable to similar measures presented by other public companies that report under IFRS or who report under U.S. GAAP and use non-GAAP financial measures to describe similar operating metrics. We refer you to yesterday's press release and our Q4 2022 earnings presentation, which are available at celestica.com under the Investor Relations tab. For more information about these and certain other non-IFRS financial measures, including a reconciliation of historical non-IFRS financial measures to the most directly comparable IFRS financial measures from our financial statements. Unless otherwise specified, all references to dollars on this call are to U.S. dollars, and per share information is based on diluted shares outstanding. Let me now turn the call over to Rob. Thank you, Craig. Good morning, everyone, and thank you for joining us on today's call. Celestica had a strong Q4 as we continue to drive solid performance despite continuing challenges presented by the macro environment. Our Q4 revenue of $2.04 billion and non-IFRS adjusted EPS of $0.56 were both above the high end of our guidance ranges. In addition, our Q4 non-IFRS operating margin and non-IFRS adjusted EPS were the highest in the company's history. 2022 was an extraordinary year for Celestica, where we achieved a number of important milestones. First, we returned to top-line revenue growth on an annual basis for the first time since 2018, following the completion of a multi-year portfolio transformation initiative. Revenue grew 29% overall and 24% organically compared to 2021, as we surpassed $7 billion in annual revenue for the first time since 2011. Second, we recorded our highest ever annual non-IFRS operating margin of 4.9%, reflecting our ability to win and deliver on higher value-added programs in alignment with our strategy. Finally, we achieved our highest ever annual non-IFRS adjusted EPS of $1.90, a 46% improvement compared to 2021. Our Lifecycle Solutions portfolio continues to be the primary driver of our growth in revenue and profitability, reflecting our strategic focus on high-value markets, where we see long-term tailwinds supporting sustainable growth. Our Lifecycle Solutions portfolio now represents roughly two-thirds of our business, achieving 39% year-over-year revenue growth as both our HPS business and our ATS segment recorded their highest revenues ever in 2022. Our ATS segment recorded 29% annual revenue growth, coming in at approximately $3 billion in revenue in 2022. With our strategic diversification and exposure to markets with strong secular tailwinds, we expect strong growth fundamentals in ATS to continue in 2023. Our CCS segment also demonstrated substantial growth in 2022, recording 29% year-over-year revenue growth and segment margin of 5.1%, the highest ever. Our strong CCS performance continues to be driven in large part by our HPS business, which achieved revenues of $1.83 billion in 2022, representing 59% year-over-year revenue growth. This growth has been supported by strong demand from our service provider customers for our differentiated offerings. We are confident that our strategic initiatives over the past several years focused on diversifying our business and growing our exposure to high-value markets will help us sustain our trajectory of strong financial performance into 2023 and over the long term. Before I offer some additional color on the outlook for each of our markets, I would like to turn the call over to Mandeep, who will provide details on our financial performance in the Q4 as well as our guidance for the Q1 of 2023. Over to you, Mandeep. Thank you, Rob, and good morning, everyone. Q4 revenue came in at $2.04 billion. This exceeded the high end of our guidance range and was 35% higher year-over-year, supported by revenue growth across each of our businesses. We achieved Q4 non-IFRS operating margin of 5.3%, 40 basis points higher year-over-year. The strong performance was driven in large part by record profitability in our CCS segment and represented the highest quarterly non-IFRS operating margin in the company's history. Non-IFRS adjusted earnings per share were $0.56 for the Q4, above the high end of our guidance range and up $0.12 year-over-year, driven by higher volumes and improved mix. ATS segment revenue was up 30% year-over-year in the Q4, higher than our expectations of a mid-20s% year-over-year increase. Year-over-year growth in ATS segment revenue was driven by the strong performance of our industrial and A&D businesses, supported by solid demand, new program ramps, and improved materials availability. ATS segment revenue accounted for 40% of total revenues in the Q4. Our CCS segment delivered another quarter of robust growth, with revenue up 39% year-over-year, driven by outperformance in both our communications and enterprise end markets. Our HPS business continues to deliver strong results, recording revenues of $491 million in the Q4, up 40% year-over-year. The growth in HPS revenue was driven by market share gains and strong demand from our service provider customers as they have continued to make significant investments in expanding data center capacity. HPS revenues were 24% of total company revenues in the Q4, up from 20% in 2021. Communications end market revenue was up 34% year-over-year, just ahead of our expectations of a low 30s percentage increase, driven by program ramps in our HPS business and improved materials availability. Enterprise end market revenue in the quarter was up 49% year-over-year, well above our expectations of a mid-20s percentage increase, driven primarily by new rack programs, increased demand in compute, and improved materials availability. Turning to segment margins. ATS segment margin was 4.4% in the Q4, 120 basis points lower year-over-year. The decline in segment margin was driven by late quarter demand shifts in capital equipment, compounded by a large number of ramping programs in industrial, partially offset by a sequential improvement in PCI. Our expectation is for ATS segment margins to expand in the coming quarters. CCS segment margin of 5.9% was up 150 basis points year-over-year. The increase was driven by strong HPS mix and operational productivity driven by improved material flow, strong service billings, and volume leverage. Moving on to some additional financial metrics. IFRS net earnings for the quarter were $42 million or $0.35 per share, compared to net earnings of $32 million or $0.26 per share in the same quarter last year. Adjusted gross margin for the Q4 was 9.4%, down 20 basis points year-over-year, primarily due to higher variable compensation. Our non-IFRS adjusted effective tax rate for the Q4 was 22.7%. Non-IFRS adjusted ROIC was 20.7% for the Q4, up 4.1% year-over-year and our highest result since 2017. Moving on to working capital. Our inventory at the end of the Q4 was $2.35 billion, up $24 million sequentially and up $653 million year-over-year. While the challenging supply chain environment has contributed and continues to contribute in driving up our inventory levels, a substantial portion of the increase is also attributable to our strong sales growth over the past two years. We continue to work collaboratively with our customers to help fund the growth in inventory, as evidenced by over $800 million in customer cash deposits at the end of the Q4, an increase of approximately $200 million sequentially and nearly $400 million year-over-year. When offsetting inventory by cash deposits, our inventory balance actually decreased by approximately $150 million compared to the previous quarter. Cash cycle days were 64 during the Q4, one day higher than the Q3 and 11 days lower than the prior year period. We are also seeing continuing signs of supply chain constraints improving, with fewer material constraints compared to previous quarters and early signs of materials lead times being reduced from record levels. While we remain diligent and proactive, we do expect to see improvements in working capital in 2023. Capital expenditures for the Q4 were $32 million, or approximately 1.6% of revenue, compared with 1.1% in the Q4 of 2021. This increase was in line with our previously communicated expectations for slightly elevated investment in the back half of the year. The increased expenditures were primarily to fund investments in our Southeast Asia and Mexico facilities in support of new program wins. Non-IFRS adjusted free cash flow was $43 million in the Q4, compared to $36 million in the prior year period. Fiscal 2022 non-IFRS adjusted free cash flow totaled $94 million, ahead of our expectations due to strong working capital management. Our expectations are to achieve at least $100 million in non-IFRS adjusted free cash flow in 2023, consistent with our long-term goal. Moving on to some additional key metrics. Our cash balance at the end of the year was $375 million, down $19 million year-over-year and up $12 million sequentially. Our cash balance, in addition to our approximately $600 million of borrowing capacity under our revolver, provide us with liquidity of approximately $1 billion, which we believe is sufficient to meet our anticipated business needs. We ended the year with gross debt of $627 million, down $20 million from the previous quarter, leaving us with a net debt position of $252 million. Our Q4 gross debt to non-IFRS trailing twelve-month adjusted EBITDA leverage ratio was 1.3 turns, down 0.2 turns sequentially and down 0.7 turns compared to the same quarter of last year. At December 31st, 2022, we were compliant with all financial covenants under our credit agreement. During the Q4, we purchased approximately 1.2 million shares for cancellation at a cost of approximately $12 million. We repurchased a total of 3.4 million shares for $35 million for cancellation during 2022. In December of 2022, the TSX accepted our new NCIB program, which permits us to purchase up to 8.8 million shares over the next 12 months. Our return of capital strategy remains consistent as we aim to return 50% of our non-IFRS adjusted free cash flow to shareholders and reinvest 50% into the business over the long term. Turning to our guidance for the Q1 of 2023. Our Q1 revenues are expected to be in the range of $1.725 billion to $1.875 billion. If the midpoint of this range is achieved, revenue will be up 15% year-over-year. Q1 non-IFRS adjusted earnings per share are expected to be in the range of $0.41 to $0.47 per share. If the midpoint of our revenue and non-IFRS adjusted EPS guidance ranges are achieved, non-IFRS operating margin will be approximately 5.0%, which will represent an increase of 60 basis points over the prior year period. Non-IFRS adjusted SG&A expense for the Q1 is expected to be in the range of $56 million to $58 million. We anticipate our non-IFRS adjusted effective tax rate to be approximately 21% for the Q1, excluding any impact from taxable foreign exchange. Now turning to our end market outlook for the Q1 of 2023. In our ATS end market, we anticipate revenue to be up in the low single-digit% range year-over-year, driven by double-digit growth in industrial and A&D, partially offset by softer demand in capital equipment. In our CCS segment, we anticipate revenues in our communication end market to be up in the high teens% range year-over-year, driven by continued strong demand from service provider customers supported by our HPS offering. Finally, in our enterprise end market, we anticipate revenue growth in the mid-30s% range year-over-year, supported by strong demand in compute. I'll now turn the call back over to Rob to provide additional color on our markets and our overall outlook. Thank you, Mandeep. After a banner year for Celestica in 2022, I'd like to start off by reaffirming our outlook for 2023, which we shared during our October conference call. To reiterate, our 2023 outlook is for revenue of at least $7.5 billion, while we are targeting non-IFRS adjusted EPS in the range of $1.95 to $2.05. These results, if achieved, would represent improvements on a year in which the company achieved record financial results in the areas of revenue, non-IFRS operating margin, and non-IFRS adjusted EPS. Our anticipated 2023 non-IFRS operating margin range is between 4.5% and 5.5%, up 50 basis points from 2022. While the broad market continues to be dynamic, we are confident in our planning and execution, as well as the resiliency of our diversified portfolio. We feel that our business is positioned to continue to outperform our broader markets and achieve strong financial results going forward. We are pleased that we are ahead of the non-IFRS adjusted EPS objective we set in our March 2022 investor call, which was to grow non-IFRS adjusted EPS at 10% or more per year for 2022 through 2025. In 2022, we grew non-IFRS adjusted EPS substantially. At the midpoint of the targeted range for 2023, our two-year average annual growth rate would be 24% for 2022 and 2023. For 2024 through 2025, our average annual non-IFRS adjusted EPS growth rate objective continues to be 10% or more. To incentivize a continuing focus on driving profitable growth, we have restructured our long-term incentive plan for senior executives by adding a non-IFRS adjusted EPS as a key performance measure. I'd like to turn to our outlook for each of our businesses. 2022 was a great year for both ATS and CCS. We expect to build on that momentum in 2023, with ATS segment revenue growing in the high single digits and CCS segment revenue growing in the low single digits. In our ATS segment, our industrial business continues to post strong results with 24% organic growth in 2022 compared to 2021, with sequential improvement in each quarter throughout the year. PCI continued to impress in 2022 as it posted strong operating results and exceeded our year one synergy targets. The outlook for our industrial business remains robust as demand is expected to continue to benefit from secular tailwinds in the green energy market, including electrical vehicles, where we are ramping a number of new programs. We expect our industrial business to have strong growth in 2023, with approximately 75% of that anticipated growth coming from green energy programs. Turning to capital equipment. Our capital equipment business had solid performance in 2022, driven by secular demand, market share gains, and strong operational execution. On our previous call, we highlighted the expectation for wafer fab equipment spending to reduce in 2023 after several years of rapid growth, with the majority of the decline coming from the memory market. We are now seeing estimates for the overall wafer fab equipment market to decline by approximately 20% in 2023, with the majority of the decline still in memory. While the overall market is expected to be down materially, we anticipate our capital equipment revenues to be down slightly in 2023 compared to 2022. The benefits of our business mix, market share gains, and new program wins are expected to enable us to outperform the broader market. Looking beyond 2023, we are encouraged that the current market outlook anticipates the wafer fab equipment market to return to growth in 2024. Turning to A&D. Our A&D business saw a strong recovery in 2022, showing sequential improvement in each quarter and double-digit annual revenue growth. In our commercial aerospace business, we continue to see a normalization of commercial air traffic towards pre-COVID levels, a trend which is anticipated to continue through 2023. Revenue in our defense business saw a double-digit growth in 2022 and is expected to maintain its solid trajectory in 2023, supported by increased military spending and investments in equipment upgrades from European and North American governments amid rising geopolitical tensions. Our HealthTech business is experiencing strong growth. Due to the nature of demand for healthcare goods and services, we believe the outlook for our HealthTech business is less sensitive to recessionary pressures. We anticipate year-over-year revenue growth in 2023, supported by new project ramps in surgical, imaging, and patient monitoring devices. Turning to our CCS segment. Our HPS business has exhibited remarkable growth over the past three years, posting an annualized growth rate of 56%, more than tripling in size. The substantial capital investment in data center expansion made by our service provider customers and our ability to gain market share from ODMs with our differentiated offerings has supported this exceptional period of performance. Based on our current market outlook, we expect to see a moderation of growth in service provider customer programs in 2023. This is primarily the result of more difficult comps after a record 2022, as well as a potential softening of demand in light of the current economic environment. Our expectation is for our HPS business to continue to see growth in 2023, however, at more moderate levels. Our outlook for our communications end market is aligned with that of our HPS business, given that it has been the primary driver of growth in recent quarters. We expect communications business to grow in 2023, but at more moderate levels due to tougher comps. In our enterprise end market, we expect the business to grow in 2023 as a result of new program ramps, but again at more moderate levels due to tougher comps. I am very pleased with what we have accomplished in 2022 and have confidence in our ability to achieve our 2023 objectives. That confidence is underpinned by our portfolio diversification, investments we have made to support meaningful growth opportunities, and our proven ability to consistently execute across our global network. I would like to close out the call by acknowledging the efforts and accomplishments of our global team, who have tirelessly worked towards the implementation and execution of our vision. The successes of the past year would not be possible without their dedication. With that, I would now like to turn the call over to the operator for questions. Thank you. Thank you. Ladies and gentlemen, we'll now begin the Q&A session. If you want to ask a question, please press star followed by one. If you want to withdraw your question, please press star followed by two. Your questions will be pulled in the order they are received. If you are using a speakerphone, please leave the handset before pressing any keys. One moment please for your first question. Your first question comes from Jim Suva from Citigroup. Please go ahead. Thank you, so much for the details. My question is, you have had tremendous success with sales to the cloud and hyperscalers over the past several years. Just wondering what type of demand indicators are you getting from that type of demand product. You mentioned that you expect enterprise, I believe you said, to grow towards the end of your prepared comments. I'm just curious about kind of hyperscalers and cloud, and are you seeing any competitive changes in that area? Thank you. Hi, Jim. Thanks for the question. Yeah, broadly speaking, with the hyperscalers and the cloud, what we're seeing in the current environment is order visibility is back to kind of normal levels. We're seeing growth tempering for most products. Some increasing due to expanded use cases, i.e., you know, it could have been part of the backplane and now it's part of the fabric. We're seeing China hyperscalers doing a little bit of a reset and creating some demand softness. On the flip side, we're still seeing growth, more moderate growth, though, coming from just about all the hyperscalers, China aside. We're still seeing customers paying premiums for air freight at lower levels than previous quarters, but still, you know, relatively strong, you know, given the current environment. Great. Thanks. As a follow-up, are you seeing any competitive changes, not just on the cloud hyperscaler stuff, but like overall business? It seems like during COVID, when nobody could get the golden screw or the missing key parts, pricing was, you know, less competitive. I'm just wondering now that availability is becoming supply more available, is pricing changing at all in the industry? I know it's always a competitive industry, but I'm wondering, or is the industry gonna turn the page to being a lot more disciplined compared to some past cycles? It's a good question. You know, given the fact that a large majority of our CCS business is now HPS, and we've established ourselves as an innovator with exceptional execution, we're not seeing, you know, I'll call it extreme pricing pressure just because of the stickiness and the design nature of the products and services that we provide to our customers. Thank you so much for the details and clarifications. Congratulations to you and all your teams. Thanks, Jim. Thank you. Your next question comes from Thanos Moschopoulos. Please go ahead. Hi. Good morning. Rob, maybe just stepping back on the macro, obviously a dynamic environment. If we think about just the change in what you're seeing over the last three months, I mean, my takeaway from your commentary is that demand's kind of pretty consistent, maybe with the exception of some softening incrementally in capital equipment, and then supply chain showing some improvement versus last quarter. Would that be fair? I mean, just again, thinking about the changes versus last quarter, anything else you'd call out, or are those the key takeaways? That's, that's right. Within ATS, we're seeing growth across all the verticals, with the exception being capital equipment. We expect that to be mildly down in 2023, largely driven by the fact that we have new program ramps. Some of them are even with new lithography customers, which shows that we're actually diversifying our capital equipment customer base, which is a huge positive. Within CCS, you know, frankly, the comps are just really tough from 2022 going to 2023. We are seeing growth across comms and enterprise and HPS, certainly into Q1 and for the full year. On, the CCS margins, which were obviously, exceptionally strong, any one-time things that may have benefited, Q4? Or, you know, is this kind of margin strength sustainable as we think about the first half of the year? Yeah. Hi, Thanos. I wouldn't say that there's one-time items to call out, but what I would say is that the our broader teams have done an exceptional job in this tough environment on maximizing pricing. There are a level of service billings that we've been seeing through 2022 for, you know, great service that we're providing our customers. As the supply chain environment starts to normalize, as lead times come in, there'll be less opportunity for those types of service billings. We do think that there'll be a slight moderation of CCS margins as we go into next year. Obviously the performance this year has been exceptional, so I think that would also be expected. Great. I'll pass the line. That's in the quarter. Thanks, Thanos. Thanks, Thanos. Thank you. Your next question comes from Paul Treiber from RBC Capital Markets. Please go ahead. Hey, thanks very much. Good morning. Just want to hone in on your comment about the late quarter demand shift that you saw in capital equipment. Could you just elaborate a bit more there, and then perhaps just indicate, you know, what led to the change versus your prior expectations going into this quarter? Sure, Paul. Within capital equipment, you know, early December, late November, some of our customers notified us that they had some inventory kind of built up in their supply chain. They wanted to defer some orders from the Q4 into the Q1. Given it happened late, we were unable to kind of flex our costs in the last couple of weeks of the month. That kind of led to a little bit of pressure. You know, that issue is now corrected, if you will, and we kinda have a beat on what we think Q1 will be and the full year will be. Supply and demand, we think is relatively aligned. Yeah. Paul, if you'll recall, when the China export controls, challenges came out, they came out right at the end of October while we were announcing our results. We provided the color that our customers had at that point. As the understanding of that became more through the quarter, our customers were able to go and reassess their near-term delivery schedules and that's why we had some of that late demand churn closer to the second half of the quarter. Okay, that's helpful. Probably adds a good understanding. As we think about 2023 and the linearity of growth within capital equipment, I mean, do you see a re-acceleration or a return to growth steadily through the year? Is it back-end loaded? Like, how should we think about that? I would say within capital equipment, you know, broadly speaking, we think that our base business will be down on a year-over-year business, but the new program ramps will be supplementing or offsetting some of those headwinds, and they will be more back-end loaded than front-end loaded. Yeah, Paul, from a market perspective, as you would know, what we're seeing in the overall market is that memory is down significantly. You're aware that we have less exposure to memory, a lot more exposure to logic. As we go through the year, what we're hearing from our customer base is that there is an expectation that there will be some demand strength as we exit 2023. Right now, we are outlooking 2023 based on what Rob has just said, the longer or medium-term fundamentals for the semi market continue to be attractive. Last question for me, just, non-lifecycle revenue has, you know, was very strong in Q4, and I think it was also strong in Q3. You know, what are the reasons for the growth, in that piece of the business? Yeah. It's primarily driven by data center growth rates as well. As you know, we do multiple things for our customers, so we can have a customer where we're doing both HPS programs and non-HPS programs with them. We actually find that being able to provide those both services creates secure relationships. When we've been seeing growth in our non-HPS programs, they're with the largely hyperscaler customers for data center deployments. That's helpful. Thank you. I'll pass the line. Thanks, Paul. Thanks, Paul. Thank you. Your next question comes from Robert Young from Canaccord Genuity. Please go off ahead. Hi. Good morning. I'm just curious about the supply chain. It sounds like there's you're expecting to be better in 2023, and I was just curious how that evolution impacts your visibility. You've benefited a lot from maybe better understanding of your customers' build schedules. You know, as footprints are changing, people, you know, shifting towards onshore, maybe away from China, how does your footprint, you know, match up with where your customers wanna go? Two questions related to supply chain there. Thanks, Rob. Yeah, from a supply chain perspective, the constraints have certainly eased from last quarter. As we enter 2023, I think we're getting close to pre-COVID levels. You know, nevertheless, supply lead times are still elevated, especially on some of the older chip technologies, such as in aerospace and some automotive products as it relates to, at least us, as it supports the EV market. You know, with respect to giving us visibility on build schedules, build schedules and visibility is really a function of lead time. Given that lead times are still relatively high, again, semiconductor lead times were about 15 weeks. They are now about 34 weeks coming off a high of 40. Based on the increased lead times for semiconductors, we still have increased lead times and visibility into our customers' forecast, which is a positive. Regarding our footprint, you know, we think we're really well-positioned right now. We announced some expansions in Malaysia to support some growth there, and we also announced some expansions in Mexico to support some growth there. That's really to facilitate customers wanting supply chain resilience and having multiple nodes supporting them, and also to support additional onshoring. Okay. Second question, I wanted to dig into the EPS guide for 2023. You said that EPS adjusted-Performance measure. It seems odd that the guide for 2023 is 5% growth and then 10% at the midpoint, 5% at the midpoint, and then 10% in 2024 and 2025. I'm just curious what the driver is that, you know, leads you to be a little more cautious on EPS growth in 2023. Hey, Rob. We've been consistent with our EPS outlook for 2023, from what we had provided in October, $1.95 to $2.05. To your point, when you look off of the very strong results that we had in 2022, it's a single-digit growth rate. 2022, as you know, was an exceptional year. If you looked at our EPS growth on a two-year stack basis, you know, we're above 20% growth. What we are seeing right now is continuing growth going into next year on the top line. We are being prudent, to be very frank at this moment, given it's January only of 2023. We would hope that we would continue to see strong performance even as we exit Q1 and going into the rest of the year. We will provide updates along the way. Right now, as you can see with our guide in Q1, the near term visibility is quite robust. Okay. Just last quickly on PCI, I think you said that you had a recovery there. Did you recover everything from the fire, and is that back to normal? I'll pass the line. Yeah. Hi, Rob. You know, as we exited, Q4, we're now at, call it pre-incident levels from a production, point of view. Yeah, we feel really good that we remained on plan to our, you know, original plan with respect to, getting back to pre-incident levels as we exited the year. Okay, thanks. Thank you. Your next question comes from Todd Coupland from CIBC. Please go ahead. Hi. Yes, good morning, everyone. I wanted to ask a couple of questions. I'll first start out on capital allocation. You've had a good experience with the PCI acquisition. It's now integrated and you're surpassing synergy targets. Are there any other M&A opportunities you're considering? Could you give us a general idea, what might fit with your footprint at the moment? Sure. I'll start off, and I'll let Rob add on as he wishes. We're pleased with the overall strength of the balance sheet. you know, gross leverage now is at 1.3x, which gives us a lot of flexibility. We're pleased with the free cash flow that we were able to generate, Todd, this year, $94 million. We're targeting over $100 million next year as well. We wanna continue to be opportunistic along the way. you know our long-term strategy is to return half of our free cash flow to our shareholders. you know, we were active in 2022 on buying back stock when the stock wasn't trading at levels that really made sense, and I say that from a multiples perspective. We continue to have that flexibility going into 2023. In terms of M&A, first off, we're extremely pleased with the performance of PCI. The business has been doing very well. They surpassed our first-year synergy targets, as was mentioned in the script, that business continues to have a very robust outlook as well. We have a very active funnel. We're continuing to look for primarily capability-based acquisitions, largely tied to our Lifecycle Solutions portfolio. Looking at targets in most of the end markets in ATS, with the exception of capital equipment, it's not really an area that we're looking to lean into from an M&A perspective. Now also looking at targets in the HPS side. We haven't pulled the trigger in 12 months. The reason for that is just because we continue to have a very robust filter. The very first thing is, does it line up with our strategic roadmaps? We wanna ensure that it's meeting our other financial filters. We continue to be open to it. We have the balance of flexibility to do it, but we're gonna be disciplined. Okay. That's, that's helpful. Thank you. If we could just step back from 2023, and if we think about the business in sort of a 3-year timeframe, what type of production shifts do you expect to take place from Asia Pac to North America? How would you anticipate Celestica participating with that? Thanks a lot. Yeah, thanks. You know, I think over a period of time, we'll see China looking to serve China, so China for Chinese markets. That might be multinationals in China that are selling products into China or Chinese customers in China serving China requirements. I think the production that has been in China, multinationals are looking to either move those to Southeast Asia or into North America or into, you know, whether that's Mexico or other requirements in North America. The broad shift, I think, is China going down, Southeast Asia growing, Mexico and North America certainly growing. Based on our footprint, we have, you know, very little exposure to China, which bodes well for us. I think about less than 10% of our sales are coming from China. You know, we have expansions going on in Malaysia, and we certainly have been expanding our Mexico facility. Last year, we opened up a new facility in, Richardson, Texas, and, that is filling up, very nicely with a very strong pipeline. You'll just see this evolve. I guess your perspective is those are the trends that are happening and you're already positioned. You just need to evolve with them as opposed to having to make any material step outs. That's well put. Yes. Yeah. Okay, great. Thanks a lot. Thanks. Thank you. Ladies and gentlemen, as a reminder, should you have a question, please press star followed by one. There are no further questions at this time. You may proceed, Mr. Mionis. Thank you. I'm pleased with our performance in the Q4 and for all of 2022. In 2022, we grew our adjusted EPS by 46%, marking another strong year of performance. In fact, over the past three years, Celestica has grown adjusted EPS by over 50%, a true testament to our ability to execute in difficult markets. I'm encouraged with the momentum we have as we enter 2023. We are well skilled at managing our business through economic cycles and feel confident in our ability to navigate through economic uncertainties. Thank you again for joining today's call. I look forward to updating you as we progress throughout the year. Ladies and gentlemen, this concludes your conference call for today. We thank you for participating and ask that you please disconnect your lines.